Abstract
Purpose
To identify the induced radionuclides produced from dental metals in proton beam therapy and investigate the accuracy of the Monte Carlo (MC) simulation by comparing the measured radioactivity.
Methods and Materials
Two dental metals of pure titanium and gold-silver-palladium alloy, commonly used in Japan, were used in this study. The dental metal placed at the center of Spread-out Bragg Peak was irradiated by 150-MeV passive scattering proton beam. The gamma rays emitted from the activated dental metals were measured using a high purity germanium (HPGe) detector. The induced radionuclides were identified from the measured gamma-ray energies. Furthermore, the Particle and Heavy Ion Transport code System v.3.24 and DCHAIN were used for the MC simulation. The measured radionuclides and their radioactivity were compared with the simulation results.
Results
In the MC simulation for the activated titanium, vanadium-47, with a half-life of 32.6 minutes had the strongest radioactivity among the induced radionuclides. The energy peaks of gamma rays emitted from titanium-51, scandium-43, scandium-44, and annihilation gamma rays were observed for the activated titanium in the HPGe detector. In the MC simulation for the activated gold-silver-palladium alloy, silver-108, with a half-life of 2.4 minutes had the strongest radioactivity. The energy peaks of gamma rays emitted from silver-104, silver-104 m, silver-108, and annihilation gamma rays were observed for the activated gold-silver-palladium alloy in the HPGe detector. Furthermore, the induced radionuclides and their radioactivity in the MC simulation were consistent with the measurement results for both dental metals, except for a few radionuclides.
Conclusions
We identify the induced radionuclides produced from 2 dental metals and compared their radioactivity between the measurements and the MC simulation. Although the identification of the induced radionuclides using the MC simulation remains uncertain, the MC simulation can be clinically effective for pre-estimating the induced radionuclides in proton beam therapy.
Introduction
Proton beam therapy (PBT) has advantages, such as the sharp lateral penumbra and steep distal fall-off at the end of its range, compared with conventional x-ray therapy. Using these physical characteristics, PBT offers a superior dose concentration for targets and can avoid delivering doses to critical organs. Recently, besides the conventional passive scattering PBT, new irradiation techniques, such as pencil beam scanning (PBS) method, have been developed, and the indications for PBT are increasing.
1- Olsen DR
- Bruland OS
- Frykholm G
- Norderhaug IN.
Proton therapy – A systematic review of clinical effectiveness.
,2Proton therapy – Present and future.
Head and neck (H&N) cancer is a good indication for PBT because some critical organs are adjacent to the target.
3- Blanchard P
- Gunn GB
- Lin A
- Foote RL
- Lee NY
- Frank SJ.
Proton therapy for head and neck cancers.
H&N cancer patients often have dental metals such as an implant or a crown in their oral cavity. Although dental metals in the oral cavity are basically removed before treatment planning, they are often irremovable. In such cases, the proton field should be arranged to avoid the metal. However, it is often difficult to avoid irradiation due to geometric and anatomic limitations. If the proton beam passes through these metals, the dose distribution is largely perturbed by the metal.
4- Newhauser WD
- Koch NC
- Fontenot JD
- et al.
Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.
, 5- Newhauser W
- Fontenot J
- Koch N
- et al.
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate.
, 6- Carnicer A
- Angellier G
- Theriat J
- Sauerwein W
- Caujolle JP
- Hérault J.
Quantification of dose perturbations induced by external and internal accessories in ocular proton therapy and evaluation of their dosimetric impact.
, 7Dosimetric accuracy of proton therapy for chordoma patients with titanium implants.
, 8- Dietlicher I
- Casiraghi M
- Ares C
- et al.
The effect of surgical titanium rods on proton therapy delivered for cervical bone tumors: experimental validation using an anthropomorphic phantom.
, 9- Jia Y
- Zhao L
- Cheng C-W
- McDonald MW
- Das IJ.
Dose perturbation effect of metallic spinal implants in proton beam therapy.
, 10- Oancea C
- Shipulin K
- Mytsin G
- et al.
Effect of titanium dental implants on proton therapy delivered for head tumors: Experimental validation using an anthropomorphic head phantom.
Moreover, high-Z metals can be radioactivated by protons or secondary neutrons in PBT. Radioactivation may increase radiation exposure in patients and therapy staff.
11- Thomadsen B
- Nath R
- Bateman FB
- et al.
Potential hazard due to induced radioactivity secondary to radiotherapy: The report of task group 136 of the American Association of Physicists in Medicine.
In PBT, particularly passive scattering PBT, patient-specific devices, such as a range compensator and a brass collimator, are often used. Therefore, the radioactivation effects of induced radionuclides and their radiation exposure have been investigated.
12- Cesana A
- Mauro E
- Silari M.
Induced radioactivity in a patient-specific collimator used in proton therapy.
,13- Lee SH
- Cho S
- You SH
- et al.
Evaluation of radioactivity induced by patient-specific devices in proton therapy.
These studies report the radioactivation of materials outside the human body. However, the radioactivation effect caused by materials inside the human body, such as dental metal, is yet to be clarified. In the conventional x-ray therapy, severe oral mucositis adjacent to dental metals was reported because of backscatter radiations.
14- Farahani M
- Eichmiller FC
- McLaughlin WL.
Measurement of absorbed doses near metal and dental material interfaces irradiated by x- and gamma-ray therapy beams.
,15- Ravikumar M
- Ravichandran R
- Sathiyan S
- Supe SS.
Backscatterd dose perturbation effects at metallic interfaces irradiated by high-energy X- and gamma-ray therapeutic beams.
Although the backscatter radiation in PBT is less of an issue than that of x-ray therapy, the dose delivered to the mucosa adjacent to the dental metal can increase because of radiation, such as beta rays and Auger electrons, emitted from the activated metal. Therefore, the radioactivation effects of the metal should be investigated. Generally, a high purity germanium (HPGe) detector is used to evaluate the radioactivation by counting the emitted gamma rays. However, it is difficult to obtain dental materials of appropriate sizes and shapes, and the overwhelming majority of radiation therapy facilities do not have the HPGe detector. Therefore, the Monte Carlo (MC) simulation can be clinically effective for estimating the induced radionuclides. In this study, we aimed to identify the induced radionuclides produced from dental metals using the MC simulation and measurement from an HPGe detector. Additionally, we also discussed the accuracy and issues of the MC simulation for evaluating the radioactivation.
Discussion
In this study, we identified the induced radionuclides produced from the dental metals, commonly used in Japan, in PBT. Energy peaks observed in the HPGe detector were in line with the simulation results except for a few induced radionuclides. The radioactivity of a few radionuclides was consistent between the measurement and the MC simulation by approximately 10%; however, that of some radionuclides deviated largely. The measurement using the HPGe detector has some uncertainties, such as a background and lack of gamma-ray counts. Also, the intranuclear cascade model in Particle and Heavy Ion Transport code System was known to have several discrepancies for low-energy (below 100 MeV) proton incident reactions.
23- Iwamoto Y
- Sato T
- Hashimoto S
- et al.
Benchmark study of the recent version of the PHITS code.
In summary, the evaluation of radionuclide production using the MC simulation is limited to the accuracy of the reaction model. Since the accuracy of reactions between metals, such as Ti, Ag, Au, and Pd, and protons is unclear, the MC simulation may include some uncertainties. Therefore, it is necessary to improve the estimation accuracy by combining the MC simulation and the measurement. However, the actual dental material may not be available for the measurement, and most radiation therapy facilities do not have a HPGe detector. Therefore, pre-estimating the induced radionuclides using the MC simulation is clinically a safe and beneficial method.
The report of task group 136 of the American Association of Physicists in Medicine proposed to survey activated materials routinely and dispose or recycle the patient-specific consumable components after completing the course of PBT and decay to the background has occurred.
11- Thomadsen B
- Nath R
- Bateman FB
- et al.
Potential hazard due to induced radioactivity secondary to radiotherapy: The report of task group 136 of the American Association of Physicists in Medicine.
Additionally, although handling of the activated material on the proton beam lines, such as the range compensator and the brass collimator, has been discussed,
12- Cesana A
- Mauro E
- Silari M.
Induced radioactivity in a patient-specific collimator used in proton therapy.
,13- Lee SH
- Cho S
- You SH
- et al.
Evaluation of radioactivity induced by patient-specific devices in proton therapy.
the effect of the activation of metals inside the human body, such as dental metal, has not been clarified in PBT and is not specified in the guideline. In the present study, we revealed that the induced radionuclides with half-lives of several hours were produced from the dental metals commonly used in Japan. The effects of the metals inside the human body on clinical outcomes are still unknown in PBT. Therefore, further research on the induced radionuclides' clinical effects is needed. There is still room for improvement in a more accurate evaluation; however, we believe that this study can help handle the standardization of these metals in PBT.
In this study, we investigated the radioactivation of the 2 metals commonly used in Japan for dental treatment. Various other dental materials, such as amalgams and composite resin were also investigated, and the radioactivation of these materials is also unclear. Since our results indicate that the MC simulation is a useful tool, the radioactivation of these materials should be further evaluated in the future. Moreover, the metal size used in this study is different from that attached to the patient's teeth. Since the dental metal is manufactured and casted, the metal size and shape vary for each patient. In this study, the dental metal radioactivation before manufacturing was verified to eliminate uncertainties of the size and shape. Although the radioactivity changes depending on the metal's size and shape, we considered that the evaluation was overestimated (clinically safe side) because the metal size used in this study is larger than that after processing. Verifications of the radioactivation using an H&N phantom would be required to simulate more realistic clinical scenario. Additionally, since the size and shape of the 2 dental metals were different, the specific radioactivity was compared. In fact, it is important to discuss doses, and the conversion from the specific radioactivity to doses is an important issue. However, few studies have reported the radioactivation of the dental metal in PBT. Thus, in this study, we focused on the identification of induced radionuclides and the usefulness of the MC simulation. Evaluating the radioactivation with doses is an important issue that should be addressed in the future. The specific radioactivity in the gold-silver-palladium alloy was larger than that in the titanium, so the activated gold-silver-palladium alloy should be carefully handled.
The clinical effects of the activated metals on patients could not be sufficiently evaluated in this study. In x-ray therapy, severe oral mucositis adjacent to dental metals was reported because of backscatter radiations from the metal.
14- Farahani M
- Eichmiller FC
- McLaughlin WL.
Measurement of absorbed doses near metal and dental material interfaces irradiated by x- and gamma-ray therapy beams.
,15- Ravikumar M
- Ravichandran R
- Sathiyan S
- Supe SS.
Backscatterd dose perturbation effects at metallic interfaces irradiated by high-energy X- and gamma-ray therapeutic beams.
Çatli reported that the dose increases to 2 mm in front of various dental implants because of the backscatter radiation in 6 MV photons when analyzed using MC simulation.
27High-density implants and radiotherapy planning: Evaluation of effects on dose distribution using pencil beam convolution algorithm and Monte Carlo method.
According to this report, however, it is unclear whether dose increases because of the backscatter radiations cause increased mucositis. Many risk factors have been identified for radiation-induced mucositis, including chemotherapy, bad oral hygiene, and smoking.
28- Maria OM
- Eliopoulos N
- Muanza T.
Radiation-induced oral mucositis.
Therefore, it is difficult to associate mucositis with the effects of dental metals in x-ray therapy. Although the mucosal dose enhancement adjacent to dental metals caused by the radioactivation is concerned in PBT, there are no reports on this issue. Therefore, the dental metal radioactivation in PBT may also be a risk factor for mucositis. In the present study, we clarified the induced radionuclides produced from the dental metals; however, the clinical effects caused by these induced radionuclides are unclear. Therefore, further research is required on the induced radionuclides' clinical effects in PBT.
This study was conducted under limited conditions. Measurements using the PBS system may be appropriate to more comprehensively evaluate the radioactivation. Recently, the PBS system has become more mainstream than the passive scattering system. There are few neutron contaminations in the PBS system. Moreover, avoiding metals is easy from proton beam fields, especially in intensity modulated proton therapy. Therefore, the dental metal radioactivation problem may be less likely to occur with the PBS system than with passive scattering. However, we speculate that it will be difficult to completely avoid metals even when using the PBS system, if the tumor is in contact with the dental metal, or if a portion of the metal is embedded in the tumor. Besides, it may be more difficult to avoid metal, particularly for reirradiation cases, because of the limited beam arrangement. In this study, we aimed to evaluate radioactivation and to investigate the usefulness of the MC simulation. This research requires having the HPGe detector. Fortunately, the HPGe detector is available at our institution, enabling us to conduct this research. Although we used the passive scattering system, we believe that our results are helpful for the PBS system. Additionally, we evaluated the radioactivation only in a certain proton beam setting since this study focused on dental metals existing the oral cavity. The anatomic position of dental metals is around a few centimeters from the body surface. Therefore, we determined that the measurement point is the center at the 150-MeV initial proton beam with the 60-mm SOBP size. However, the radioactivation by higher energy proton beams is a very interesting issue. We would like to evaluate a comprehensive verification of the energy dependence of the radioactivation in the near future.
Article info
Publication history
Published online: December 25, 2022
Accepted:
December 11,
2022
Received:
May 5,
2022
Footnotes
Sources of support: This work was supported by JSPS KAKENHI grant number JP20K16775.
Disclosures: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Research data are stored in an institutional repository and will be shared upon request to the corresponding author.
Copyright
© 2022 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.